| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $377.3M | — | +1.2% |
| Cost of Revenue | $146.4M | — | +8.4% |
| Gross Profit | $230.9M | — | -2.9% |
| R&D Expense | $39.4M | — | +8.4% |
| SG&A Expense | $57.5M | — | +1.3% |
| Operating Income | $81.3M | — | -20.3% |
| Pre-tax Income | $156.4M | — | +62.0% |
| Income Tax | $38.0M | — | +61.1% |
| Net Income | $118.4M | — | +62.3% |
| EPS (Basic) | $1.83 | — | +72.6% |
| EPS (Diluted) | $1.80 | — | +76.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $498.6M | +38.8% | -46.9% |
| Accounts Receivable | $355.7M | -0.8% | +2.0% |
| Inventory | $61.3M | -5.2% | -11.3% |
| Current Assets | $942.3M | +4.7% | -33.8% |
| Total Assets | $2.35B | +5.4% | +14.2% |
| Current Liabilities | $333.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $125.1M | — | +16.3% |
| Capital Expenditures | $3.2M | — | -63.0% |
| Investing Cash Flow | $26.0M | — | +140.8% |
| Financing Cash Flow | -$11.6M | — | +36.2% |
| Free Cash Flow | $121.9M | — | +23.3% |
| +34.3% |
| Long-term Debt | $569.6M | +0.2% | +0.6% |
| Total Liabilities | $1.13B | -0.3% | +27.3% |
| Stockholders' Equity | $1.21B | +11.2% | +4.1% |